Characterization of a Novel Molecular Pathway in Autoimmunity
Manuel Galvan, Ph.D.
Researcher, Des Moines University
Dr. Galvan recently started at Des Moines University working with Dr. Suzanne Bohlson. Their laboratory focuses on phagocyte recognition and clearance events with the goal of developing therapies that strengthen the body’s ability to ingest and kill infectious particles or dead/dying cells. Specific cells in the body are designed to ingest dangerous particles, such as invading bacteria. These professional eating cells, or phagocytes, also eat dead or dying cells. This process of clearance of dead or dying cells is necessary to allow for the repair of damaged tissue, and to maintain normal tissue. When this process of cellular ingestion (phagocytosis) is dysregulated, the body becomes susceptible to chronic infections and autoimmunity.
- Comprehend the role of macrophages in apoptotic cell clearance.
- Comprehend why lack of apoptotic cell clearance leads to autoimmunity.
- Asses apoptotic cell clearance using in-vitro assays.
Des Moines University (DMU) prohibits discrimination in employment, educational programs, and activities on the basis of race, national origin, color, creed, religion, sex, age, disability, veteran status, sexual orientation, gender identity, or associational preference. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored events. If you are a person with a disability who requires an accommodation in order to participate in this activity, please contact the DMU Continuing Medical Education office at 515-271-1596 or email@example.com.